20 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Here's Why You Should Retain Teladoc (TDOC) Stock for Now https://www.zacks.com/stock/news/2204509/here-s-why-you-should-retain-teladoc-tdoc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204509 Jan 02, 2024 - Teladoc's (TDOC) Integrated Care business is expected to gain from margin expansion and improving chronic care program enrollment.
Teladoc (TDOC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates https://www.zacks.com/stock/news/2228928/teladoc-tdoc-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228928 Feb 20, 2024 - The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Teladoc (TDOC) Flat As Market Gains: What You Should Know https://www.zacks.com/stock/news/2242466/teladoc-tdoc-flat-as-market-gains-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2242466 Mar 18, 2024 - Teladoc (TDOC) reachead $15.12 at the closing of the latest trading day, reflecting no change compared to its last close.
Here's Why Investors Should Hold Teladoc (TDOC) Stock Now https://www.zacks.com/stock/news/2247654/here-s-why-investors-should-hold-teladoc-tdoc-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2247654 Mar 28, 2024 - Teladoc's (TDOC) Integrated Care business is expected to gain from margin expansion and improving chronic care program enrollment.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for https://www.zacks.com/stock/news/2257683/analysts-estimate-teladoc-tdoc-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257683 Apr 18, 2024 - Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings https://www.zacks.com/stock/news/2227030/higher-visits-to-soften-cost-blow-for-teladoc-tdoc-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227030 Feb 15, 2024 - Teladoc's (TDOC) fourth-quarter results are likely to reflect growth in BetterHelp's profit levels.
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors https://www.zacks.com/stock/news/2245687/teladoc-tdoc-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2245687 Mar 25, 2024 - The latest trading day saw Teladoc (TDOC) settling at $15.08, representing a +0.53% change from its previous close.
Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1? https://www.zacks.com/stock/news/2260395/can-higher-visits-soften-cost-blow-for-teladoc-tdoc-in-q1?cid=CS-ZC-FT-analyst_blog|earnings_preview-2260395 Apr 23, 2024 - Teladoc's (TDOC) first-quarter results are expected to have benefited from higher visits. However, high costs might have partially offset the positives.
Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2262708/teladoc-tdoc-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2262708 Apr 25, 2024 - Teladoc (TDOC) delivered earnings and revenue surprises of -4.26% and 1.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2262799/teladoc-tdoc-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2262799 Apr 25, 2024 - Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Pages: 12

<Page 2